相关实验视频
Updated: Jun 11, 2026

16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
20.7K
基于诱导的IgA脏病患者的移植结果:UNOS数据分析
Emmanuel Albert Aydin-Ghormoz1, Jason Perlmutter1, Naoru Koizumi2
1Department of Medicine, Albany Medical Center, New York, USA.
Clinical transplantation
|December 21, 2023
概括
诱导阿勒姆图祖马布增加了移植后IgA脏病的复发. 没有类固醇的血红蛋白在已故的捐赠移植中提供了对移植存活率和死亡率的最佳结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- IgA脏病 (IgAN) 是导致末期脏病 (ESKD) 的主要原因.
- 移植是对IGAN的ESKD次要治疗的选择.
- 了解免疫抑制对Igan患者移植结果的影响至关重要.
研究的目的:
- 评估诱导和维持免疫抑制策略对IGAN复发的影响.
- 评估不同免疫抑制方案对Igan患者移植后的移植存活率和患者死亡率的影响.
- 确定与IGAN复发和不良移植结果相关的因素.
主要方法:
- 联合国卫生署 (2000-2022) 数据库对成年IgAN移植接受者的回顾性分析.
- 诱导药物 (甲基球蛋白,阿勒姆图祖马布,巴西力西马布/达克利祖马布) 和维持免疫抑制 (CNI,MMF,类固醇) 的比较.
- 多变量后勤和考克斯回归分析,卡普兰-梅尔生存分析.
主要成果:
- 在活体捐赠脏移植 (LDKTs) 和已故捐赠脏移植 (DDKTs) 两种情况下,Alemtuzumab的诱导与IgAN复发的增加有关.
- 没有类固醇的血红蛋白 (ATG) 与IGAN复发,移植失败和DDKTs死亡率的风险较低有关.
- 在LDKTs和DDKTs中,Igan复发是移植失败和死亡的重要风险因素.
结论:
- 阿拉姆图祖马布的诱导策略与移植后IGAN复发的更高风险相关.
- 没有使用类固醇的血红蛋白 (ATG) 似乎与最低的移植损失和死亡率有关,特别是在DDKTs中.
- 通过优化免疫抑制来最大限度地减少IgAN复发对于改善长期移植存活率和降低移植接受者的死亡率至关重要.
相关概念视频
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

